Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

NCT03326388 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis Type 1
Plexiform Neurofibroma
Optic Nerve Glioma

Interventions

DRUG: Selumetinib

Sponsor

Great Ormond Street Hospital for Children NHS Foundation Trust

Collaborators

[object Object]